Mobile telecare system for intensive insulin treatment and patient education. First applications for newly diagnosed type 1 diabetic patients

International Journal of Artificial Organs

Volumn 29, Issue 11, 2006, Pages 1074-1081

  Ładyzdyński, Piotr ^a   Wojcicki J M ^a   Krzymien J ^b   Foltynski P ^a   Migalska Musial K ^a   Tracz, M ^b   Karnafel, W ^b  

^a INSTITUTE OF BIOCYBERNETICS AND BIOMEDICAL ENGINEERING   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Artificial pancreas; Diabetes mellitus; Distance patient education; Mobile telecare; Newly diagnosed type 1 diabetes; Remote consultation; Telemedicine

Indexed keywords

ARTIFICIAL ORGANS; PATIENT TREATMENT; TELEMEDICINE;

ARTIFICIAL PANCREAS; DIABETES MELLITUS; DISTANCE PATIENT EDUCATION; INSULIN TREATMENT; MOBILE TELECARE; NEWLY DIAGNOSED TYPE 1 DIABETES; PATIENT EDUCATION; REMOTE CONSULTATION; TELECARE; TYPE 1 DIABETES;

INSULIN;

GLUCOSE; HEMOGLOBIN A1C; INSULIN ASPART; INSULIN DERIVATIVE; ISOPHANE INSULIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; COMPUTER SYSTEM; CONTROLLED STUDY; DIABETIC PATIENT; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; EDUCATION PROGRAM; ELECTRONIC DATA INTERCHANGE; ELECTRONIC MEDICAL RECORD; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH CARE FACILITY; HEALTH CARE SYSTEM; HEMOGLOBIN DETERMINATION; HOME CARE; HUMAN; HYPERGLYCEMIA; HYPOGLYCEMIA; INSULIN DEPENDENT DIABETES MELLITUS; INTENSIVE CARE; LOW DRUG DOSE; MALE; MEDICAL SPECIALIST; PATIENT EDUCATION; PHYSICIAN; QUALITY OF LIFE; SELF ESTEEM; TELECONSULTATION; TREATMENT DURATION;

EID: 33845919254     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880602901108     Document Type: Article

References (24)

1. Mazze RS, Shamoon H, Pasmantier R, Lucido D, Murphy J, Hartmann K, Kuykendall V, Lopatin W. Reliability of blood glucose monitoring by patients with diabetes mellitus. Am J Med 1984; 77: 211-7.
2. Ładyzyński P, Wójcicki JM, Józwicka E, Blachowicz J, Krzymień J. Reliability of blood glucose self-monitoring and its influence on glycemic control in highly motivated type 1 diabetic patients. Diabetes Care 1999; 22: 854-6.
3. Billiard A, Rohmer V, Roques MA, Joseph MG, Suraniti S, Giraud P, Limal JM, Fressinaud P, Marre M. Telematic transmission of computerized blood glucose profiles for IDDM patients. Diabetes Care 1991; 14: 130-4.
4. Ahring KK, Ahring JP, Joyce C, Farid NR. Telephone modem access improves diabetes control in those with insulin-requiring diabetes. Diabetes Care 1992; 15: 971-5.
5. Ładyzyński P, Wójcicki JM, Krzymień J, Blachowicz J, Józwicka E, Czajkowski K, Janczewska E, Karnafel W. Teletransmission system supporting intensive insulin treatment of out-clinic type 1 diabetic pregnant women. Technical assessment during 3 years' application. Int J Artif Organs 2001; 24: 157-63.
6. Bellazzi R, Larizza C, Montani S, Riva A, Stefanelli M, d'Annunzio G, Lorini R, Gómez EJ, Hernando E, Brugues E, Cermeno J, Corcoy R, de Leiva A, Cobelli C, Nucci G, Del Prato S, Maran A, Kilkki E, Tuominen J. A telemedicine support for diabetes management: The T-IDDM project. Comput Methods Programs Biomed 2002; 69: 147-61.
7. Gómez EJ, Hernando ME, Garcia A, Del Pozo F, Corcoy R, Brugues E, Cermeno J, de Leiva A. Telemedicine as a tool for intensive management of diabetes: DIABTel experience. Comput Methods Programs Blomed 2002; 69: 163-77.
8. 2DM project. The experience of two Italian clinical sites with clinical evaluation of a multi-access service for the management of diabetes mellitus patients. Methods Inf Med 2006; 45: 79-84.
9. Shultz EK, Bauman A, Hayward M, Holzman R. Improved care of patients with diabetes through telecommunications. Ann N Y Acad Sci 1992; 670: 141-5.
10. Albisser AM, Harris RI, Sakkal S, Parson ID, En Chao SC. Diabetes intervention in the information age. Med Inform (Lond) 1996; 21: 297-316.
11. Montori VM, Helgemoe PK, Guyatt GH, Dean DS, Leung TW, Smith SA, Kudva YC. Telecare for patients with type 1 diabetes and Inadequate glycemic control. A randomized controlled trial and meta-analysis. Diabetes Care 2004; 27: 1088-94.
12. Shea S, Weinstock RS, Starren J, Teresi J, Palmas W, Field L, Morin P, Goland R, Izquierdo RE, Wolff LT, Ashraf M, Hilliman C, Silver S, Meyer S, Holmes D, Petkova E, Capps L, Lantigua RA. A randomized trial comparing telemedicine case management with usual care in older, ethnically diverse, medically underserved patients with diabetes mellitus. J Am Med Inform Assoc 2006; 3: 40-51.
13. Fallucca F, Di Blase N, Sabbatini A, Borrello E, Sciullo E, Napoli A. Telemedicine in the treatment of diabetic pregnancy. Practical Diabetes Int 1996; 13: 115-8.
14. Wójcicki JM, Ładyzyński P, Krzymień J, Józwicka E, Blachowicz J, Janczewska E, Czajkowski K, Karnafel W. What we can really expect from telemedicine in intensive diabetes treatment. Results from 3-years study on type 1 pregnant diabetic women. Diabetes Technol Ther 2001; 3: 581-9.
15. Morrish NJ, Cohen DL, Hicks B, Keen H. A controlled study of the effect of computer-aided analysis of home blood glucose monitoring on blood glucose control. Diabet Med 1989; 6: 591-4.
16. Marrero DG, Kronz KK, Golden MP, Wright JC, Orr DP, Fineberg NS. Clinical evaluation of computer-assisted self-monitoring of blood glucose system. Diabetes Care 1989; 12: 345-50.
17. Marrero DG, Vandagriff JL, Kronz K, Fineberg NS, Golden MP, Gray D, Orr DP, Wright JC, Johnson NB. Using telecommunication technology to manage children with diabetes: The Computer-Linked Outpatient Clinic (CLOC) Study. Diabetes Educ 1995; 21: 313-9.
18. Farmer AJ, Gibson OJ, Dudley C, Bryden K, Hayton PM, Terassenko L, Neil A. A randomized controlled trial of the effect of real-time telemedicine support on glycemic control in young adults with type 1 diabetes. Diabetes Care 2005; 28: 2697-702.
19. Farmer A, Gibson OJ, Thrassenko L, Neil A. A systematic review of telemedicine interventions to support blood glucose self-monitoring in diabetes. Diabet Med 2005; 22: 1372-8.
20. Wójcicki JM. "J"-index. A new proposition of the assessment of current glucose control in diabetic patients. Horm Metab Res 1995; 27: 41-42.
21. Chantelau E. Decay of haemoglobin A1c upon return to normoglycemia. Diabetologia 1992; 35: 191.
22. Recasens M, Aguilera E, Morinigo R, Casamitjana R, Nicoletti F, Gomis R, Conget I. Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving b-cell function at onset of type 1 diabetes mellitus. Diabetes Res Clin Pract 2003; 60: 153-9.
23. Lombardo F, Valenzise M, Wasniewska M, Messina MF, Ruggeri C, Arrigo T, De Luca F. Two-year prospective evaluation of the factors affecting honeymoon frequency and duration in children with insulin dependant diabetes mellitus: the key-role of age at diagnosis. Diabetes Nutr Metab 2002; 15: 246-51.
24. Albisser AM, Hodel AS, Albisser JB, Wanner A. Chronic disease management: A system model relating outcomes, reporting, monitoring, interventions and satisfaction. Control Eng Pract 2002; 10: 101-10.